Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma

C. H. Hsu, T. S. Yang, C. Hsu, H. C. Toh, R. J. Epstein, L. T. Hsiao, P. J. Chen, Z. Z. Lin, T. Y. Chao, A. L. Cheng

Research output: Contribution to journalArticlepeer-review

103 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences